Apr. 24, 2024 — In a breakthrough for cancer research, scientists have created lab-grown mini-colons that can accurately mimic the development of colorectal tumors, offering a powerful new tool ...

The Food and Drug Administration issued six approvals for solid tumors in June, including thyroid, endometrial, colorectal, breast and ovarian cancers. From Judge Frank Caprio opening up about his ...

In its early stages, colorectal cancer may not have symptoms. Problems that cause symptoms usually start after it has spread. Anyone can get colorectal cancer. Doctors often don't know why it ...

Cancer — including cancer that metastasizes, or spreads, to form new tumors elsewhere in the body — is named after the primary site. For example, colon cancer that spreads to the liver is called ...

Sep. 13, 2024 — A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in ...

The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white patients, ...

Colon cancer, which affects the large intestine, is one of the most common cancers in the United States. Medical experts typically group it with rectal cancer in a category called colorectal cancer.

Most people with cancer of the colon or rectum undergo surgery to remove the tumor while sparing healthy tissue. Our surgeons use techniques such as: Abdominoperineal resection (APR) ­— This may be ...

Taking race into account when developing tools to predict a patient's risk of colorectal cancer leads to more accurate ...

Between May 2005 and February 2009, a total of 45 colorectal tumors in 45 patients were resected by ESD at Tochigi Cancer Center, and the data for these cases were accumulated on a prospectively ...

the genomic testing of tumors was routine practiced only for people with certain solid tumors, such as melanoma, lung cancer, and colon cancer. MSK-IMPACT is much more inclusive. It can be used on any ...

The results of our retrospective study suggest that ESD can be a promising technique for the treatment of colorectal tumors, offering an excellent outcome in comparison with EMR.